HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wal-Mart RFID rollout

This article was originally published in The Rose Sheet

Executive Summary

Procter & Gamble, Unilever, Gillette and Johnson & Johnson are among the eight manufacturers testing electronic product codes at seven Wal-Mart supercenters in the Dallas/Forth Worth area in the first phase of the retail chain's radiofrequency identification program. The trial will include 21 products, and additional suppliers may be added, according to Wal-Mart. All of the retailer's top 100 suppliers must have RFID tags carried on cases and pallets distributed to Wal-Mart stores by January 2005. P&G and Gillette were early advocates of alternatives to the universal product code as sponsors of the Massachusetts Institute of Technology Auto-ID Center, which developed RFID ("1The Rose Sheet" Oct. 1, 1999, p. 6)...

You may also be interested in...



P&G, Gillette First Sponsors Of MIT Auto-ID Research Center

Alternatives to Universal Product Codes employed on retail products will be developed at a new Massachusetts Institute of Technology research center co-funded by Procter & Gamble and Gillette. Establishment of the project was announced in conjunction with the recent 25th anniversary of the UPC.

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.

Partisan Politics Returns To US FDA Congressional Oversight

The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012123

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel